4-N-[2-[1-(cyclohexylmethyl)-5-[3-(trifluoromethoxy)phenyl]indol-3-yl]ethyl]cyclohexane-1,4-diamine
C30H38F3N3O — CID 160659882
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-N-[2-[1-(cyclohexylmethyl)-5-[3-(trifluoromethoxy)phenyl]indol-3-yl]ethyl]cyclohexane-1,4-diamine
4-N-[2-[1-(cyclohexylmethyl)-5-[3-(trifluoromethoxy)phenyl]indol-3-yl]ethyl]cyclohexane-1,4-diamine (PubChem CID 160659882) has the molecular formula C30H38F3N3O and a molecular weight of 513.65 g/mol. Its IUPAC name is 4-N-[2-[1-(cyclohexylmethyl)-5-[3-(trifluoromethoxy)phenyl]indol-3-yl]ethyl]cyclohexane-1,4-diamine.
Molecular Properties
| Compound Name | 4-N-[2-[1-(cyclohexylmethyl)-5-[3-(trifluoromethoxy)phenyl]indol-3-yl]ethyl]cyclohexane-1,4-diamine |
|---|---|
| PubChem CID | 160659882 |
| Molecular Formula | C30H38F3N3O |
| Molecular Weight | 513.65 g/mol |
| Exact Mass | 513.30 |
| IUPAC Name | 4-N-[2-[1-(cyclohexylmethyl)-5-[3-(trifluoromethoxy)phenyl]indol-3-yl]ethyl]cyclohexane-1,4-diamine |
| SMILES | NC1CCC(NCCc2cn(CC3CCCCC3)c3ccc(-c4cccc(OC(F)(F)F)c4)cc23)CC1 |
| InChI | InChI=1S/C30H38F3N3O/c31-30(32,33)37-27-8-4-7-22(17-27)23-9-14-29-28(18-23)24(15-16-35-26-12-10-25(34)11-13-26)20-36(29)19-21-5-2-1-3-6-21/h4,7-9,14,17-18,20-21,25-26,35H,1-3,5-6,10-13,15-16,19,34H2 |
| InChIKey | WJAOLLABOWRLRX-UHFFFAOYSA-N |
| XLogP | 7.19 |
| TPSA | 52.21 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 513.65 |
| LogP ≤ 5 | 7.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160659882 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.